Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Thomas Peyret's publication output changed over time?
ScholarIQpublication output · 2008–2025
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2025.
1
2
2
1
1
2
1
1
20082015201620212022202320242025
What are the most-cited papers on Thomas Peyret?
ScholarIQmost cited works
Population pharmacokinetics of bevacizumab in cancer patients with external validation
Kelong Han, Thomas Peyret, Mathilde Marchand, Angelica Quartino, Nathalie Gosselin, Sandhya Girish, David E. Allison, Jin Jin
S117498271. 201673 CitationsOPEN ACCESS
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage
JE Edwards, Carl LaCerte, Thomas Peyret, NH Gosselin, Jean‐Francois Marier, Hofmann Af, Д. А. Шапиро
S106654227. 201651 CitationsOPEN ACCESS
Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation
Kelong Han, Thomas Peyret, Angelica Quartino, Nathalie Gosselin, Sridharan Gururangan, Michela Casanova, Johannes H. M. Merks, Maura Massimino, Jacques Grill, Najat C. Daw, Fariba Navid, Jin Jin, David E. Allison
S13842274. 201543 CitationsOPEN ACCESS
Population pharmacokinetic and pharmacodynamic analyses from a 4‐month intradose escalation and its subsequent 12‐month dose titration studies for a human monoclonal anti‐FGF23 antibody (KRN23) in adults with X‐linked hypophosphatemia
Xiaoping Zhang, Thomas Peyret, Nathalie Gosselin, Jean‐Francois Marier, Erik A. Imel, Thomas O. Carpenter
The Journal of Clinical Pharmacology. 201527 CitationsOPEN ACCESS
An integrated QSPR–PBPK modelling approach for<i>in vitro–in vivo</i>extrapolation of pharmacokinetics in rats
E. Kamgang, Thomas Peyret, Kannan Krishnan
S56681374. 200820 Citations
Related on ScholarIQ
Population pharmacokinetics of bevacizumab in cancer patients with external validation
Paper
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage
Paper
Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation
Paper
Population pharmacokinetic and pharmacodynamic analyses from a 4‐month intradose escalation and its subsequent 12‐month dose titration studies for a human monoclonal anti‐FGF23 antibody (KRN23) in adults with X‐linked hypophosphatemia
Paper
An integrated QSPR–PBPK modelling approach for<i>in vitro–in vivo</i>extrapolation of pharmacokinetics in rats
Paper
Rapid and Accurate Diagnosis of Dermatophyte Infections Using the DendrisCHIP® Technology
Paper